The table below provides a sample list of items in the ADNI Data Archive.
Main Category | Subcategory | Item |
---|---|---|
Assessments | Diagnosis | Diagnosis and Symptoms Checklist [ADNI1,GO,2] |
Assessments | Diagnosis | Diagnostic Summary – Baseline Changes [ADNI1,GO,2,3] |
Assessments | Diagnosis | Diagnostic Summary [ADNI1,GO,2,3] |
Assessments | Neuropsychological | ADAS Sub-Scores and Total Scores [ADNI1] |
Assessments | Neuropsychological | ADSP Phenotype Harmonization Consortium (PHC) – Composite Cognitive Scores [ADNI1,GO,2,3] |
Assessments | Neuropsychological | Alzheimer’s Disease Assessment Scale (ADAS) [ADNI1] |
Assessments | Neuropsychological | Alzheimer’s Disease Assessment Scale (ADAS) [ADNIGO,2,3] |
Assessments | Neuropsychological | Clinical Dementia Rating Scale (CDR) [ADNI1,GO,2,3] |
Assessments | Neuropsychological | Cognitive Change Index [ADNI2,3] |
Assessments | Neuropsychological | Cogstate Battery Results [ADNI2,3] |
Assessments | Neuropsychological | Cogstate Brief Battery [ADNI3] |
Assessments | Neuropsychological | Embic Corporation’s Digital Cognitive Biomarkers |
Assessments | Neuropsychological | Everyday Cognition – Participant Self Report [ADNIGO,2,3] |
Assessments | Neuropsychological | Everyday Cognition – Study Partner Report [ADNIGO,2,3] |
Assessments | Neuropsychological | Financial Capacity Instrument Short Form (FCI-SF) [ADNI3] |
Assessments | Neuropsychological | Functional Activities Questionnaire (FAQ) [ADNI1,GO,2,3] |
Assessments | Neuropsychological | Geriatric Depression Scale (GDS) [ADNI1,GO,2,3] |
Assessments | Neuropsychological | Mini-Mental State Examination (MMSE) [ADNI1,GO,2,3] |
Assessments | Neuropsychological | Modified Hachinski Ischemia Scale [ADNI1,GO,2,3] |
Assessments | Neuropsychological | Montreal Cognitive Assessment (MoCA) [ADNIGO,2,3] |
Assessments | Neuropsychological | Neuropsychiatric Inventory (NPI) [ADNI2,3] |
Assessments | Neuropsychological | Neuropsychiatric Inventory Questionnaire (NPI-Q) [ADNI1,GO,2,3] |
Assessments | Neuropsychological | Neuropsychological Battery [ADNI1,GO,2,3] |
Assessments | Neuropsychological | UW – Neuropsych Summary Scores [ADNI1,GO,2,3] |
Assessments | Non-clinical Assessments | Brain Health Registry: BASELINE QUESTIONNAIRE [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: EVERYDAY COGNITION [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: LONGITUDINAL QUESTIONNAIRE [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: MEMTRAX [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: STUDY PARTNER ADL [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: STUDY PARTNER CAREGIVER BURDEN [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: STUDY PARTNER EVERYDAY COGNITION [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: STUDY PARTNER FAQ [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: STUDY PARTNER INITIAL [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: STUDY PARTNER RELATIONSHIP [ADNI3] |
Assessments | Non-clinical Assessments | Brain Health Registry: STUDY PARTNER STUDY CONFIRMATION [ADNI3] |
Biospecimen | Biosample Inventory | Aliquot Count in the LDMS Database [ADNI1,GO,2,3] |
Biospecimen | Biosample Inventory | Residual Aliquot Count in the LDMS Database [ADNIGO,2] |
Biospecimen | Biospecimen Results | UPENN – 2D-UPLC tandem mass spectrometry measurement of Abeta42, Abeta40 and Abeta38 adjustment of Abeta42 results to CRM. [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | AD Metabolomics Consortium Barcelona Purines |
Biospecimen | Biospecimen Results | AD Metabolomics Consortium Bile Acids – Post Processed Data [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | AD Metabolomics Consortium Bile Acids [ADNI1] |
Biospecimen | Biospecimen Results | ADMC Duke Biocrates P180 Kit Flow injection analysis [ADNI1] |
Biospecimen | Biospecimen Results | ADMC Duke Biocrates p180 Kit Flow injection analysis [ADNIGO,2] |
Biospecimen | Biospecimen Results | ADMC Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography [ADNI1] |
Biospecimen | Biospecimen Results | ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNIGO,2] |
Biospecimen | Biospecimen Results | ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1] |
Biospecimen | Biospecimen Results | ADMC Lipidomics Meikle Lab Longitudinal Data Matrix [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | ADMC M2OVE-AD ADNIGO-2 Bile Acids[ADNIGO,2] |
Biospecimen | Biospecimen Results | ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1] |
Biospecimen | Biospecimen Results | ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal[ADNI1,GO,2] |
Biospecimen | Biospecimen Results | ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | ADMC Phenomenome Phosphatidylcholine, Lysophosphatidylcholine Flow Injection Negative Ionization LC-MS/MS Internal Std Ratios |
Biospecimen | Biospecimen Results | ADMC Phenomenome Phosphatidylcholine, Lysophosphatidylcholine, Sphingomyeline Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios |
Biospecimen | Biospecimen Results | ADMC Phenomenome Phosphatidylethanolamine, Plasmenylethanolamine Flow Injection LC-MS/MS Internal Std Ratios |
Biospecimen | Biospecimen Results | ADMC Phenomenome Phosphatidylethanolamine, Plasmenylethanolamine Flow Injection LC-MS/MS Peak Heights [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | ADMC Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples [ADNI1] |
Biospecimen | Biospecimen Results | ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | ADNI Biomarker Core Laboratory. Baseline Isoprostanes Data [ADNI1] |
Biospecimen | Biospecimen Results | ADNI3 URMC Lab Data |
Biospecimen | Biospecimen Results | ApoE – Results [ADNI1,GO,2,3] |
Biospecimen | Biospecimen Results | Araclon Biotech S.L. AB test40 and 42 Plasma Analysis [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNIGO,2] |
Biospecimen | Biospecimen Results | Biomarker Samples [ADNI1,GO,2,3] |
Biospecimen | Biospecimen Results | Biomarkers Consortium CSF Proteomics MRM Data [ADNI1] |
Biospecimen | Biospecimen Results | Blennow Lab – CSF NFL [ADNI 1] |
Biospecimen | Biospecimen Results | Blennow Lab – CSF Ng [ADNI1] |
Biospecimen | Biospecimen Results | Blennow Lab – Plasma Tau [ADNI1] |
Biospecimen | Biospecimen Results | Blennow Lab ADNI1 Plasma neurofilament light (NFL) [ADNI1] |
Biospecimen | Biospecimen Results | Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | Blennow Lab CSF GAP 43 [ADNIGO,2] |
Biospecimen | Biospecimen Results | CSF – Local Lab Results [ADNI1,GO,2,3] |
Biospecimen | Biospecimen Results | CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington) [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | CSF soluble triggering receptor expressed on myeloid cells 2 (sTREM2) and progranulin (PGRN) [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | DDE Analysis Summary [ADNI 1] |
Biospecimen | Biospecimen Results | Diadem – AlzoSure Predict |
Biospecimen | Biospecimen Results | Emory University CSF Targeted MS [ADNIGO,2] |
Biospecimen | Biospecimen Results | EUROIMMUN CSF Beta-Amyloid [ADNIGO,2] |
Biospecimen | Biospecimen Results | Fagan Lab – CSF Visinin-like Protein-1 (VILIP-1) [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc [ADNI2,3] |
Biospecimen | Biospecimen Results | FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix [ADNI2,3] |
Biospecimen | Biospecimen Results | FNIH Biomarkers Consortium Plasma Abeta Project: Roche [ADNI2,3] |
Biospecimen | Biospecimen Results | FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu [ADNI2,3] |
Biospecimen | Biospecimen Results | FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg [ADNI2,3] |
Biospecimen | Biospecimen Results | FNIH Biomarkers Consortium Plasma Abeta Project: Wash U[ADNI1,GO,2] |
Biospecimen | Biospecimen Results | Fujirebio Beta-Amyloid Ratio [ADNIGO,2] |
Biospecimen | Biospecimen Results | Homocysteine – Results [ADNI1] |
Biospecimen | Biospecimen Results | Hu Lab CSF inflammatory proteins [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | Institut Agro-ecole Interne Agrocampus Ouest Lipids in Red Blood Cells [ADNI3] |
Biospecimen | Biospecimen Results | Meso Scale Diagnostics Analysis of Residual CSF Samples [ADNIGO,2] |
Biospecimen | Biospecimen Results | Rader Lab ADNI 1 Lipids CAD ALZ [ADNI1] |
Biospecimen | Biospecimen Results | Redox Reactive Autoantibodies [ADNI1] |
Biospecimen | Biospecimen Results | University of Gothenburg Longitudinal Plasma P-tau181 [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | UPENN – 2D-UPLC tandem mass spectrometry measurement of Abeta42, Abeta40 and Abeta38 [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | UPENN – 2D-UPLC tandem mass spectrometry measurement of Abeta42, Abeta40 and Abeta38 [ADNI1] |
Biospecimen | Biospecimen Results | UPENN – ADNI/DIAN Study CSF Elecsys Results [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | UPENN – Plasma Biomarker Data [ADNI1] |
Biospecimen | Biospecimen Results | UPENN CSF Biomarker Master [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | UPENN CSF Biomarkers Elecsys [ADNI1,GO,2,3] |
Biospecimen | Biospecimen Results | UPENN CSF Biomarkers Elecsys [ADNI1,GO,2,3] |
Biospecimen | Biospecimen Results | UPENN CSF Biomarkers Elecsys [ADNI1,GO,2] |
Biospecimen | Biospecimen Results | UW – CSF Alpha-synuclein [ADNI1] |
Biospecimen | Biospecimen Results | UW – CSF Complement 3 & Factor H [ADNI1] |
Biospecimen | Biospecimen Results | UW – Plasma EV Apogee [ADNI1,GO,2] |
Biospecimen | Lab Collection Procedures | ApoE Genotyping – Draw Data [ADNI1,GO] |
Biospecimen | Lab Collection Procedures | Clinical Laboratory Tests [ADNI1,GO,2,3] |
Biospecimen | Lab Collection Procedures | Genetic Sample Collection [ADNI2,3] |
Biospecimen | Lab Collection Procedures | Laboratory Data [ADNI1,GO, 2] |
Biospecimen | Lab Collection Procedures | Method of CSF Collection [ADNI1,GO] |
Curated Data Cuts | Curated Data & Docs | ADNI-DIAN Comparison Study Data Subset |
Enrollment | Enrollment | Additional Comments [ADNI1,GO,2,3] |
Enrollment | Enrollment | ADNI 2 Visit Codes Lookup [ADNI2] |
Enrollment | Enrollment | Arm [ADNI1,GO,2] |
Enrollment | Enrollment | Clinician Verification [ADNI3] |
Enrollment | Enrollment | Clinician Verification [ADNIGO,2] |
Enrollment | Enrollment | Early Discontinuation and Withdrawal [ADNI1,GO,2] |
Enrollment | Enrollment | Exclusion Criteria [ADNI1] |
Enrollment | Enrollment | Inclusion Criteria [ADNI1] |
Enrollment | Enrollment | Neuropathology Status [ADNI2,3] |
Enrollment | Enrollment | Registry [ADNI1,GO,2,3] |
Enrollment | Enrollment | Roster [ADNI1,GO,2,3] |
Enrollment | Enrollment | Study Visits Summary |
Enrollment | Enrollment | Visits [ADNI1,GO,2,3] |
Genetic | Genotype Results | Desikan Lab Polygenic Hazard Score (PHS) [ADNI1,GO,2] |
Genetic | Genotype Results | TOMM40 PolyT Variant Data [ADNI1] |
Genetic | Other Genetic Data & Info | ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders [ADNIGO,2] |
Imaging | MR Image Acquisition | 1.5T MRI Scan Information [ADNI1,GO,2,3] |
Imaging | MR Image Acquisition | 3T MRI Scan Information [ADNI1,GO,2,3] |
Imaging | MR Image Acquisition | MP-RAGE Metadata Listing [ADNI1,GO,2] |
Imaging | MR Image Acquisition | MRI B1 Calibration [ADNI1] |
Imaging | MR Image Acquisition | MRI Clinical Read [ADNI1] |
Imaging | MR Image Acquisition | MRI Phantom [ADNI1] |
Imaging | MR Image Acquisition | MRI Protocol [ADNI1] |
Imaging | MR Image Acquisition | MRI Scan Metadata Listing [ADNI1,GO,2,3] |
Imaging | MR Image Acquisition | MRI Serial [ADNI1] |
Imaging | MR Image Acquisition | MRI Subject Inclusion [ADNI1,GO,2] |
Imaging | MR Image Analysis | ASHS volume data [ADNI2,3] |
Imaging | MR Image Analysis | BAI – MRI NMRC Summaries [ADNI1,GO,2] |
Imaging | MR Image Analysis | Fox Lab – BSI Measures [ADNI1,GO,2,3] |
Imaging | MR Image Analysis | Mayo (Jack Lab) – Default Mode Network Connectivity [ADNIGO,2] |
Imaging | MR Image Analysis | Mayo (Jack Lab) – Network Failure Quotient for rs-fMRI [ADNIGO,2,3] |
Imaging | MR Image Analysis | Mayo (Jack Lab) – TBM-SyN Based Scores [ADNIGO,2,3] |
Imaging | MR Image Analysis | MRI Infarcts [ADNI1,GO,2,3] |
Imaging | MR Image Analysis | UA – MRI SPM Voxel Based Morphometry (VBM) Analysis [ADNI1] |
Imaging | MR Image Analysis | UCD – Total Cranial Vault Segmentation [ADNI1] |
Imaging | MR Image Analysis | UCD – White Matter Hyperintensity Volumes [ADNI1,GO,2,3] |
Imaging | MR Image Analysis | UCD – White Matter Hyperintensity Volumes [ADNI1] |
Imaging | MR Image Analysis | UCD – White Matter Hyperintensity Volumes [ADNIGO,2] |
Imaging | MR Image Analysis | UCL – Boundary Shift Integral Summaries [ADNI1] |
Imaging | MR Image Analysis | UCSD – Derived Volumes [ADNI1] |
Imaging | MR Image Analysis | UCSF – ADNI-1 3T Cross-Sectional FreeSurfer (5.1) [ADNI1] |
Imaging | MR Image Analysis | UCSF – ASL Perfusion CBF by FreeSurfer ROI [ADNI3] |
Imaging | MR Image Analysis | UCSF – ASL Perfusion CBF by FreeSurfer ROI [ADNIGO,2] |
Imaging | MR Image Analysis | UCSF – Cross-Sectional FreeSurfer (5.1) [ADNI1,GO,2] |
Imaging | MR Image Analysis | UCSF – Cross-Sectional FreeSurfer (6.0) [ADNI3] |
Imaging | MR Image Analysis | UCSF – Cross-Sectional FreeSurfer (FreeSurfer Version 4.3) [ADNI1,GO,2] |
Imaging | MR Image Analysis | UCSF – Longitudinal FreeSurfer (5.1) – All Available Base Image [ADNIGO,2] |
Imaging | MR Image Analysis | UCSF – Longitudinal FreeSurfer (5.1) – Final Run w/ All A [ADNIGO,2] |
Imaging | MR Image Analysis | UCSF – Longitudinal FreeSurfer (FreeSurfer Version 4.4) [ADNI1,GO,2] |
Imaging | MR Image Analysis | UCSF – Longitudinal FreeSurfer (FreeSurfer Version 5.1) – Year 1 Base Image [ADNIGO,2] |
Imaging | MR Image Analysis | UCSF – Regional Atrophy Rates [ADNI1] |
Imaging | MR Image Analysis | UCSF – SNT Hippocampal Volumes [ADNI1] |
Imaging | MR Image Analysis | UPENN – Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods [ADNI1] |
Imaging | MR Image Analysis | UPENN – Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD) [ADNI1] |
Imaging | MR Image Analysis | UPENN – Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI) [ADNI1] |
Imaging | MR Image Analysis | USC – DTI ROI Summary Measures v1 [ADNIGO,2] |
Imaging | MR Image Analysis | USC – DTI ROI Summary Measures v2 (Mean) [ADNI3] |
Imaging | MR Image Analysis | USC – DTI ROI Summary Measures v2 (Robust Mean)[ADNI3] |
Imaging | MR Image Analysis | USC – Tensor-based Morphometry Versions 2.0 and 2.1 [ADNI1,GO,2,3] |
Imaging | MR Image Analysis | USC – Tensor-based Morphometry Versions 2.0 and 2.1 [ADNI1,GO,2,3] |
Imaging | MR Image Quality | Listing of Changed LONI Study IDs [ADNI1,GO,2] |
Imaging | MR Image Quality | Mayo (Jack Lab) – ADNI 3 MRI QC |
Imaging | MR Image Quality | Mayo (Jack Lab) – ADNI GO/2 MRI QC [ADNIGO,2] |
Imaging | MR Image Quality | Mayo (Jack Lab) – ADNI MRI MCH [ADNIGO,2,3] |
Imaging | MR Image Quality | MRI MPRAGE Process [ADNI1] |
Imaging | MR Image Quality | MRI MPRAGE Ranking [ADNI1] |
Imaging | MR Image Quality | MRI Quality [ADNI1] |
Imaging | MR Image Quality | UCSF – ASL Perfusion Raw QC [ADNIGO,2] |
Imaging | PET Image Acquisition | Amyloid PET Scan Information [ADNI3] |
Imaging | PET Image Acquisition | AV-45 PET Scan Information [ADNIGO,2] |
Imaging | PET Image Acquisition | FDG PET Scan Information [ADNI1] |
Imaging | PET Image Acquisition | FDG PET Scan Information [ADNI3] |
Imaging | PET Image Acquisition | FDG PET Scan Information [ADNIGO,2] |
Imaging | PET Image Acquisition | PET Metadata Listing [ADNI1,GO,2] |
Imaging | PET Image Acquisition | PIB Scan Information [ADNI1] |
Imaging | PET Image Acquisition | Tau AV-1451 PET Eligibility [ADNI2] |
Imaging | PET Image Acquisition | Tau AV-1451 PET Scan Information [ADNI2] |
Imaging | PET Image Acquisition | Tau AV-1451 PET Scan Information [ADNI3] |
Imaging | PET Image Analysis | BAI – NMRC Summaries [ADNI1] |
Imaging | PET Image Analysis | BAI – PET NMRC AV45 Summaries [ADNIGO,2,3] |
Imaging | PET Image Analysis | BAI – PET NMRC FDG Summaries [ADNI1,GO,2,3] |
Imaging | PET Image Analysis | BAI – PET NMRC Flortaucipir (F-AV1451) Summaries [ADNI2,3] |
Imaging | PET Image Analysis | BAI – PET NMRC Summaries [ADNI1,GO,2,3] |
Imaging | PET Image Analysis | Cross-Validation [ADNI1] |
Imaging | PET Image Analysis | NYU FDG-PET Hippocampus (pons normalized) [ADNI1] |
Imaging | PET Image Analysis | sPAP Avid ADNI Florbetapir Summaries [ADNIGO,2] |
Imaging | PET Image Analysis | UC Berkeley – AV1451 PVC Analysis [ADNI2,3] |
Imaging | PET Image Analysis | UC Berkeley – AV45 Analysis [ADNIGO,2,3] |
Imaging | PET Image Analysis | UC Berkeley – FBB Analysis [ADNI3] |
Imaging | PET Image Analysis | UC Berkeley – FDG Analysis [ADNI1,GO,2,3] |
Imaging | PET Image Analysis | UC Berkeley – AV1451 Analysis [ADNI2,3] |
Imaging | PET Image Analysis | UPitt – PIB PET Analysis [ADNI1] |
Imaging | PET Image Analysis | UU – PET Analysis (Norman Foster) [ADNI1,GO,2] |
Imaging | PET Image Quality | Amyloid PET QC [ADNI3] |
Imaging | PET Image Quality | AV-45 PET QC Tracking [ADNIGO,2] |
Imaging | PET Image Quality | FDG PET QC [ADNI3] |
Imaging | PET Image Quality | PET QC Tracking [ADNI1,GO,2] |
Imaging | PET Image Quality | PIB QC Tracking [ADNI1] |
Imaging | PET Image Quality | Tau AV-1451 PET QC [ADNI2] |
Imaging | PET Image Quality | Tau AV-1451 PET QC [ADNI3] |
Medical History | Adverse Events | Adverse Events Log [ADNI3] |
Medical History | Adverse Events | Adverse Events/ Hospitalizations [ADNI1,GO,2] |
Medical History | Adverse Events | AV-45 24-48 Hour Follow-Up [ADNIGO,2] |
Medical History | Drugs | Concurrent Medications Log [ADNI1,GO,2,3] |
Medical History | Drugs | Key Background Medications [ADNIGO,2,3] |
Medical History | Medical History | Documentation of Baseline Symptoms Log [ADNI1,GO,2] |
Medical History | Medical History | Initial Health Assessment [ADNI3] |
Medical History | Medical History | Medical History [ADNI1,GO,2] |
Medical History | Medical History | Recent Medical History Details Log [ADNI1,GO,2] |
Medical History | Physical/Neurological Exams | AV-45 Pre and Post Injection Vitals [ADNIGO,2] |
Medical History | Physical/Neurological Exams | Baseline Symptoms Checklist [ADNI1,GO,2] |
Medical History | Physical/Neurological Exams | ECG [ADNI2] |
Medical History | Physical/Neurological Exams | Neurological Exam [ADNI1,GO,2,3] |
Medical History | Physical/Neurological Exams | Physical Exam [ADNI1,GO,2,3] |
Medical History | Physical/Neurological Exams | Vital Signs [ADNI1,GO,2,3] |
Neuropathology | Neuropathology Results | NACC Neuropathology Data Form (ADNI1, GO, 2, 3) |
Neuropathology | Neuropathology Results | NACC Neuropathology Data Form [ADNI1,GO,2] |
Study Info | Data & Database | ADNIMERGE – Key ADNI tables merged into one table [ADNI1,GO,2,3] |
Study Info | Data & Database | Deleted Scan Listing |
Study Info | Data & Database | Return of Research Results [ADNI2,3] |
Subject Characteristics | Family History | Family History – Parents [ADNI3] |
Subject Characteristics | Family History | Family History – Sibling Log [ADNI3] |
Subject Characteristics | Family History | Family History Questionnaire [ADNI1,GO,2] |
Subject Characteristics | Family History | Family History Questionnaire Subtable [ADNI1,GO,2] |
Subject Characteristics | Subject Demographics | Subject Demographics [ADNI1,GO,2,3] |